Install
Stay informed on the latest biopharmaceutical news, trends, and developments in Asia Pacific with BioPharma APAC. BioPharma Asia ( APAC ) provides in-depth analysis, insights, and expert commentary on drug development, regulatory updates, and industry partnerships in the region.
- 665articles · 180d
- 2+ day agolatest article
- Mar 23, 2026earliest in window
- 93%with images
- 260avg words
- Medical 427
- Health & Wellness 354
- Health 253
- Business & Industrial 245
- Economy, Business & Finance 230
- Science & Technology 171
- Science & Nature 134
- Finance & Business 64
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Dayspring Pharma's CG2001 Meets Phase II Endpoint in Male Androgenetic Alopecia Trial
3+ mon, 4+ day ago (180+ words) 09 June 2026 | Tuesday | News CG2001 is a topical fixed-dose combination formulation containing minoxidil and finasteride, being evaluated for the treatment of male androgenetic alopecia. The trial consisted of the following treatment arms: CG2001 (5% Minoxidil and 0.075% Finasteride) once daily (QD); CG2001 (5% Minoxidil and 0.1% Finasteride) once…...
Dayspring Pharma Reports Positive Phase II Results For CG2001 In Androgenetic Alopecia
4+ mon, 2+ week ago (210+ words) 23 April 2026 | Thursday | News Dayspring Pharma announced top-line data from its Phase II clinical trial of CG2001 foam in male patients with androgenetic alopecia (AGA). The trial met its primary endpoint and demonstrated statistically significant and clinically meaningful results, with a favorable…...